Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities

Please find below a podcast of Prof Ian Glaspole discussing new analyses investigating the efficacy and safety of nintedanib in patients with IPF who are elderly or who have multiple comorbidities.

blue mic

Glaspole I et al. Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities. Respir Res 2021;22(1):125

Header - Navigation Icon

The authors meet criteria for authorship as recommended by the International Committee of Medical Journal Editors (ICMJE). The authors did not receive payment for development of this podcast or the manuscript on which this podcast was based. Editorial support was provided by Elizabeth Ng, BSc and Wendy Morris, MSc of FleishmanHillard, London, UK, which was contracted and funded by Boehringer Ingelheim. Boehringer Ingelheim was given the opportunity to review the manuscript and podcast for medical and scientific accuracy as well as intellectual property considerations.